Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Nucl Med ; 31(9): 534-7, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16921276

ABSTRACT

Cutaneous angiosarcoma of the scalp is a rare highly aggressive malignant tumor that typically afflicts elderly patients and commonly presents with extensive local spread and distant metastasis. Distant metastases favor lung, liver, lymph nodes, and skin. Overall, the prognosis is poor. It differs from other soft tissue sarcomas in that the size of the lesion at presentation instead of tumor grade is the important prognostic factor. Optimal treatment is yet to be determined. Wide-margin complete excision with postoperative radiotherapy has been the most effective therapy. Chemotherapy and gene therapy have been used with some success. Local extent is critical in surgical planning, especially in the head and face, and is difficult to determine accurately with clinical examination and morphologic imaging tools. We report the case of a 70-year-old man diagnosed with multifocal angiosarcoma of the scalp. PET/CT imaging with F-18 2-fluoro-2-deoxyglucose (F-18 FDG) not only showed avid FDG uptake by an angiosarcoma (SUVmax = 10.7), but also simultaneously showed local extension of multifocal lesions with periosteal involvement and excluded metastatic abdominal nodal disease. PET/CT imaging after chemotherapy and before radiation therapy showed complete resolution of FDG uptake in the scalp and osseous lesions. Evaluation of more cases of this subset of soft tissue sarcoma with FDG PET/CT may suggest a possible role in not only staging angiosarcomas to determine the extent of local as well as distant disease, but also to potentially help determine response to therapy and early recognition of local or distant recurrence.


Subject(s)
Fluorodeoxyglucose F18 , Hemangiosarcoma/diagnostic imaging , Hemangiosarcoma/diagnosis , Neoplasm Staging/methods , Positron-Emission Tomography/methods , Radiopharmaceuticals , Scalp/pathology , Skin Neoplasms/diagnostic imaging , Skin Neoplasms/diagnosis , Tomography, X-Ray Computed/methods , Aged , Biopsy , Humans , Male , Prognosis
2.
Clin Nucl Med ; 28(5): 389-91, 2003 May.
Article in English | MEDLINE | ID: mdl-12702935

ABSTRACT

PURPOSE: The authors describe the variability of Tc-99m exametazime-labeled leukocyte distribution as a function of the relative frequency of white cell types in the labeled blood. MATERIALS AND METHODS: A 76-year-old man who was hospitalized with fever and possible postoperative osteomyelitis underwent scintigraphic imaging with Tc-99m exametazime-labeled leukocytes. RESULTS: The white cell scan excluded any discrete focus of infection and revealed diffuse involvement of the lymph nodes and skin. The pathologic diagnosis was angioimmunoblastic T-cell lymphoma. The atypical infiltrates seen on the white cell scan can be explained by the severe eosinophilic blood count on the day of leukocyte labeling (total leukocyte count: 8,100 cells/microl with 63% neutrophils, 8.9% lymphocytes, and 22.2% eosinophils). CONCLUSION: In the labeling of the leukocyte moiety, a higher presence of any leukocyte subpopulation will modify the biodistribution and thus the image interpretation.


Subject(s)
Leukocytes/diagnostic imaging , Lymphoma, T-Cell/diagnostic imaging , Prosthesis-Related Infections/diagnostic imaging , Technetium Tc 99m Exametazime , Whole-Body Counting/methods , Aged , Diagnosis, Differential , Eosinophilia/etiology , Eosinophilia/pathology , Fever of Unknown Origin/etiology , Humans , Knee Prosthesis/adverse effects , Lymphoma, T-Cell/blood , Lymphoma, T-Cell/complications , Male , Prosthesis-Related Infections/etiology , Radionuclide Imaging , Radiopharmaceuticals
SELECTION OF CITATIONS
SEARCH DETAIL
...